TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
TVRD

Tvardi Therapeutics, Inc.

Healthcare · Biotechnology

1.60$ -6.4% vs. previous close Closing price · As of: Sep 17, 2026

Statements

Balance Sheet

Tvardi Therapeutics, Inc. (TVRD) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 18 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet TVRD
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
115 27 90 72 51 44 28 44 39 32 26 18
101 26 81 64 48 44 23 43 38 32 25 17
63 23 47 49 39 38 11 21 21 21 20 16
79 23 70 57 44 38 22 41 36 31 25 16
5.7 4.0 2.9 1.8 1.4 4.5 2.2
3.3 2.7 1.6 0.6 0.9 0.9
0.3
0.4 0.4 0.4 0.4 0.4 0.3 0.3 0.3 0.3
30 89 60 61 51 48 43 11 11 11 11 9.1
23 3.3 15 14 10 4.0 7.0 11 11 11 11 9.1
0.5 0.1 0.2 0.2 3.4 0.1 0.1 0.1 0.1 0.1 0.1
8.0 1.6 5.0 6.8 2.5 1.4 1.7 2.4 4.1 3.2 4.6 4.6
30
86 -62 30 12 0.7 -4.6 -15 33 28 21 15 8.4
-652 -63 -715 -735 -748 -756 -102 -98 -103 -110 -117 -124
1.5 9.4 9.4 1.5 1.5 1.5 9.4 8.5 9.4 9.4 9.4 9.4

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?